
Cardiac device manufacturer setting new standards in arrhythmia monitoring with AtriAmp.
Atrility Medical, founded with the mission to revolutionize cardiac care, focuses on setting new standards in arrhythmia monitoring. The company’s flagship product, AtriAmp, is designed to provide precise and continuous monitoring of cardiac rhythms, particularly in intensive care units (ICUs). Atrility Medical aims to enhance patient outcomes through innovative technology that offers real-time data and improved diagnostic capabilities for healthcare providers.
Notable figures associated with Atrility Medical include key industry experts and investors who support its mission to advance cardiac care. The company has achieved significant milestones, including successful clinical trials and widespread adoption of AtriAmp in leading medical institutions. Atrility Medical's impact is evident in its contribution to more accurate arrhythmia detection and better patient management, positioning it as a leader in the cardiac device industry.

Atriomx

iRhythm
irhythmtech.com

Altrix Medical
altrixmedical.com

AtaCor Medical
atacor.com

Atrion
atrioncorp.com

Aatru Medical
aatru.com

Atraverse Medical

Innerpulse

Protaryx Medical
protaryx.com

Medical Device Innovations

Ativa Medical

Mirtle Medical
mirtlemed.com

Maxwell Biomedical

ReliantHeart
reliantheart.com

AtriCure
atricure.com
Companies similar to Atrility Medical include Atriomx, iRhythm, Altrix Medical and AtaCor Medical.
Atrility Medical was founded in 2017.
Atrility Medical's headquarters is located in Madison, WI, US.
Atrility Medical's most recent funding round was for $3.4M (USD) in June 2022.
As of Jun 9, 2022, Atrility Medical has raised a total of $4M (USD).
Atrility Medical has 9 employees as of Feb 5, 2024.